Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Kordower, Jeffrey
Item TypeName
Concept Dependovirus
Academic Article Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
Academic Article Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.
Academic Article A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
Academic Article Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Academic Article AAV2-Neurturin for Parkinson's Disease: What Lessons Have We Learned?
Academic Article Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys.
Academic Article Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
Academic Article Transgene expression, bioactivity, and safety of CERE-120 (AAV2-neurturin) following delivery to the monkey striatum.
Academic Article Introduction: gene therapy has gone from a pipe dream to clinical reality.
Academic Article Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.
Academic Article Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease.
Academic Article Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease.
Academic Article Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point.
Academic Article Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?
Academic Article Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease.
Academic Article Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
Academic Article Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.
Academic Article Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
Academic Article Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
Academic Article Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
Academic Article Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with a-synucleinopathies.
Academic Article Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
Academic Article Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9.
Search Criteria
  • Dependovirus